
David Duane Hurd MD
Professor, Internal Medicine, Bowman Gray School of Medicine of Wake Forest Univ
Join to view full profile
S Hawthorne RdWinston-Salem, NC 27157
Phone+1 336-716-2255
Dr. Hurd is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaResidency, Internal Medicine, 1976 - 1978
University of MinnesotaInternship, Internal Medicine, 1974 - 1975
University of Illinois College of MedicineClass of 1974
Certifications & Licensure
NC State Medical License 1989 - 2026
MN State Medical License 1975 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
- Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer
- Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
Publications & Presentations
PubMed
- Cognitive Performance in Patients With Multiple Myeloma Treated With an Autologous Stem Cell Transplant: Results of the Brilliant Study.Cesar Rodriguez, Melanie Tam, David Hurd, Emily V Dressler, Sarada Krishnamurthy
Clinical Lymphoma, Myeloma & Leukemia. 2025-12-01 - 3 citationsA phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.Todd A Fehniger, Marcus P Watkins, Nkiruka Ezenwajiaku, Fei Wan, David D Hurd
Haematologica. 2024-03-01 - 358 citationsTriplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.Paul G Richardson, Susanna J Jacobus, Edie A Weller, Hani Hassoun, Sagar Lonial
The New England Journal of Medicine. 2022-07-14
Press Mentions
Vaccination Mandates for Healthcare Workers: Updates from 4 StatesNovember 2nd, 2021
Empire State Weekly: Federal Judge Blocks Health Care Vaccine MandateOctober 15th, 2021
Judge Sides with NY Health Care Workers Seeking Religious Exemption to COVID Vaccination MandatesOctober 12th, 2021
Grant Support
- Clinical Trial: Selenium And Vitamin E Cancer Prevention Trial (SELECT)National Center For Research Resources2008–2010
- Cancer And Leukemia Group BNational Cancer Institute1999–2008
- Selenium And Vitamin E Cancer Prevention Trial (SELECT)National Center For Research Resources2007
- Detection Of MDS Using Fish In Pretransplant SamplesNational Cancer Institute2001–2002
- Cancer And Leukemia Group BNational Cancer Institute1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: